In addition, FOXO1 also inhibits the proliferation and growth of cancer cells in chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) [28,29], thereby exerting antitumor effects in hematological tumors. This evidence concerns the gene FOXO1 and cancer.